Stay updated with breaking news from Christopher Bamba. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Philippine Canadian Inquirer PH, US ink deals on energy, health, Internet satellites, climate tech
Photo courtesy of NTF Against Covid-19 MANILA - Local pharmaceutical firm Lloyd Laboratories Inc. (LLI) is eyeing a "fill and finish" operation for a new Chinese vaccine against coronavirus disease (Covid-19) that is still undergoing clinical trials. In a virtual media interview Thursday, LLI medical consultant Dr. Antonio Ligsay said the company has partnered with Livzon Biotech's Livzon Mabpharm, Inc. for the phase three clinical trial of the V-01, a code name for the recombinant vaccine against Covid-19. Ligsay said the interim analysis will be concluded by the end of this mon...
Molnupiravir(Antara) MANILA - As Philippine pharmaceutical firm Lloyd Laboratories Inc. (LLI) aims producing molnupiravir in the country, prices of this coronavirus disease 2019 (Covid-19) drug could go down by 30 to 50 percent. LLI Business Development director Christopher Bamba said retail prices of imported molnupiravir cost around PHP100 to PHP150 per 200-milligram capsule. "For our pricing, we are usually 30 to 50 percent lower and this is our price strategy being a local manufacturer and a generic company," Bamba said in a media interview Thursday. If the local production will ...
Lloyd Laboratories Inc., a firm eyeing to start its production of Molnupiravir this month, is also aiming to apply for an emergency use authorization (EUA) by February for a Covid-19 vaccine that is currently under clinical trials. Antonio Ligsay, medical consultant of the company, told the reporters on Thursday that…